73 results on '"Pandey, Ambarish"'
Search Results
2. Effect of liraglutide on thigh muscle fat and muscle composition in adults with overweight or obesity: Results from a randomized clinical trial
3. Association of diabetes‐specific heart failure risk score with presence of subclinical cardiomyopathy among individuals with diabetes: A prospective study
4. An exercise enigma: Unravelling the complexity of exercise intolerance in heart failure with preserved ejection fraction
5. Effect of liraglutide on thigh muscle fat and muscle composition in adults with overweight or obesity: Results from a randomized clinical trial
6. Understanding the language of the heart: The promise of natural language processing to diagnose heart failure with preserved ejection fraction
7. From Prediction to Prevention: The Role of Heart Failure Risk Models
8. Artificial intelligence and heart failure: A state‐of‐the‐art review
9. Sex differences in long‐term outcomes following acute heart failure hospitalization: Findings from the Get With The Guidelines‐Heart Failure registry
10. Pharmaco‐disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries
11. Frailty and heart failure: State‐of‐the‐art review
12. Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society
13. Are post‐influenza vaccine reactions truly ‘adverse’?
14. The Texas Health Resources Clinical Scholars Program: Learning healthcare system workforce development through embedded translational research
15. Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus
16. Heart failure quality of care and in‐hospital outcomes during the COVID ‐19 pandemic: findings from the Get With The Guidelines‐Heart Failure registry
17. Genetic variation in sodium glucose co‐transporter 1 and cardiac structure and function at middle age
18. Trends and characteristics of hospitalizations for heart failure in the United States from 2004 to 2018
19. Incorporation of natriuretic peptides with clinical risk scores to predict heart failure among individuals with dysglycaemia
20. Improving exercise tolerance and quality of life in heart failure with preserved ejection fraction – time to think outside the heart
21. Physical frailty in older patients with acute heart failure: From risk marker to modifiable treatment target
22. Omics, machine learning, and personalized medicine in heart failure with preserved ejection fraction: promising future or false hope?
23. Prefrailty, impairment in physical function, and risk of incident heart failure among older adults
24. The other striated muscle: The role of sarcopenia in older persons with heart failure
25. Targeting the nitrate–nitrite–nitric oxide pathway in heart failure with preserved ejection fraction: too soon to say no to nitric oxide?
26. Diagnostic and prognostic implications of heart failure with preserved ejection fraction scoring systems
27. Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT
28. Racial Differences and Temporal Obesity Trends in Heart Failure with Preserved Ejection Fraction
29. Impact of body mass index on surgical coronary revascularization for ischaemic heart failure: insights from STICHES
30. Long‐term predictive value of stroke volume index obtained from right heart catheterization: Insights from the veterans affairs clinical assessment, reporting, and tracking program
31. Towards global improvement in heart failure care
32. Phenomapping of patients with heart failure with preserved ejection fraction using machine learning‐based unsupervised cluster analysis
33. Sex differences in cardiac function, biomarkers and exercise performance in heart failure with preserved ejection fraction: findings from the RELAX trial
34. Identifying a low‐flow phenotype in heart failure with preserved ejection fraction: a secondary analysis of the RELAX trial
35. Wake Forest University long‐term follow‐up of type 2 myocardial infarction: The Wake‐Up T2MI Registry
36. Temporal association between hospitalization event and subsequent risk of mortality among patients with stable chronic heart failure with preserved ejection fraction: insights from the TOPCAT trial
37. Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT
38. Developing evidence‐based and accountable health policy in heart failure
39. Prognostic implications of microvascular complications in patients with diabetes and heart failure with reduced ejection fraction
40. Perturbations in serum chloride homeostasis in heart failure with preserved ejection fraction: insights from TOPCAT
41. The heart failure readmission quagmire: taking a deep dive to find solutions
42. Response to Endurance Exercise Training in Older Adults with Heart Failure with Preserved or Reduced Ejection Fraction
43. His‐Bundle Pacing for Identifying Optimal Ablation Sites in Patients Undergoing Atrioventricular Junction Ablation
44. Cost‐Effectiveness of Therapeutic Drug Monitoring in Diagnosing Primary Aldosteronism in Patients With Resistant Hypertension
45. YouTube as a source of information on dialysis: A content analysis
46. Laparoscopic repair of iatrogenic diaphragmatic hernia following radiofrequency ablation for hepatocellular carcinoma
47. Development and validation of a machine learning-based approach to identify high-risk diabetic cardiomyopathy phenotype.
48. A novel controlled metabolic accelerator for the treatment of obesity-related heart failure with preserved ejection fraction: Rationale and design of the Phase 2a HuMAIN trial.
49. Association of global longitudinal strain by feature tracking cardiac magnetic resonance imaging with adverse outcomes among community-dwelling adults without cardiovascular disease: The Dallas Heart Study.
50. Optimal cardiometabolic health and risk of heart failure in type 2 diabetes: an analysis from the Look AHEAD trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.